Newsroom
Welcome to the ADA Newsroom.
Get the latest news from ADA, including press releases and research announcements. If you are looking for ADA press releases issued prior to 2019, please email press@diabetes.org.
American Diabetes Association Highlights Novel Agent Retatrutide which Results in Substantial Weight Reduction in People with Obesity or Type 2 Diabetes During Late Breaking Symposium
Today, findings from two phase 2 clinical trials showcase new data for an investigational, once-weekly injectable glucose-dependent…Read more
New Study Shows a Coordinated Care Approach Significantly Improves Quality of Care for Patients with Type 2 Diabetes and Heart Disease
Today, findings from the COORDINATE-Diabetes trial demonstrated that multi-disciplinary care between cardiologists, diabetes specialists…Read more
American Diabetes Association Releases Updates to the 2023 Standards of Care in Diabetes on the Use of Teplizumab in Delaying the Onset of Type 1 Diabetes
Today, the American Diabetes Association® (ADA) published updates to the Standards of Care in Diabetes—2023 (Standards of Care) on the use…Read more
Meet Our Experts
If you would like to speak to our subject matter experts please contact press@diabetes.org
Charles D. Henderson
Chief Executive Officer
Robert Gabbay, MD, PhD
Chief Scientific and Medical Officer
Simone Grapini-Goodman
Chief Marketing & Digital Officer
Lisa Murdock
Chief Advocacy Officer
Nuha El Sayed
Vice President, Health Care Improvement
Marlon Pragnell
Vice President, Research & Science
Crystal Woodward
Director of Safe at School
Advocacy news
Read the latest news from the Advocacy Insider, ADA’s newsletter dedicated to advocacy.
